Similarly, in an experimental autoimmune encephalomyelitis model, RAGE-deficient mice exhibited disease severity comparable to wild-type controls, whereas treatment with soluble RAGE decoy protein markedly reduced inflammation and clinical signs [89]. Here, AGER is linked to experimental autoimmune encephalomyelitis.